S3 cannabidiol proposal

TGA scheduling delegate proposes pharmacist-only dispensing of low-dose cannabidiol The Therapeutic Goods Administration (TGA) Joint scheduling committee is set to hear a delegate-initiated proposal to allow pharmacist-only supply of low dose cannabidiol products. The move follows the conclusions of a TGA review that concluded S3 dispensing of cannabidiol presents a good safety and tolerability profile

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous ‘A supply chain in distress.’
Next Research Roundup